India's cumulative Covid-19 vaccination coverage crosses 850 mn mark

India's COVID-19 vaccination coverage has crossed the 85 crore mark, the Union Health Ministry informed on Sunday.

coronavirus, coronavirus vaccine,
A woman receives a dose of Covaxin, during a vaccination drive at an under-construction flyover in New Delhi (Photo: Reuters)
ANI General News
2 min read Last Updated : Sep 26 2021 | 1:30 PM IST

India's COVID-19 vaccination coverage has crossed the 85 crore mark, the Union Health Ministry informed on Sunday.

"With the administration of 68,42,786 vaccine doses in the last 24 hours, India's COVID-19 vaccination coverage crossed the landmark of 85 Cr (85,60,81,527) as per provisional reports till 7 am today. This has been achieved through 83,64,110 sessions," an official release.

The Ministry informed that the recovery of 26,032 patients in the last 24 hours has increased the cumulative tally of recovered patients (since the beginning of the pandemic) to 3,29,02,351.

"Consequently, India's recovery rate stands at 97.77 per cent. The recovery rate is currently at its highest peak since March 2020," the release said.

It further said that the active caseload is presently 3,03,476, which constitute 0.90 per cent of the country's total positive Cases.

The testing capacity has also been enhanced across the country, and the weekly positivity rate at 1.98 per cent remains less than 3 per cent for the last 93 days now, the ministry noted.

The daily positivity rate stands at 1.90 per cent. The daily positivity rate has remained below 3 per cent for the last 27 days and below 5 per cent for 110 consecutive days now.

According to the release, more than 83.54 crore (83,54,12,250) vaccine doses have been provided to states/UTs so far through the government of India (free of cost channel) and through direct state procurement category.

"Further, more than 1.17 crore doses (1,17,12,275) are in the pipeline. More than 4.56 crore (4,56,96,920) balance and unutilised COVID vaccine doses are still available with the states/UTs to be administered," it added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineVaccination

First Published: Sep 26 2021 | 1:30 PM IST

Next Story